The market offers growth opportunities driven by increased demand for personalized medicine, advancements in cell and gene ...
For companies such as HRV Pharma out of India, the standardized scale of manufacturing has expanded alongside its ...
Lupin Manufacturing Solutions’ Dabhasa facility in India supports API development and commercial-scale manufacturing, forming ...
Predictive maintenance fails not from bad models, but broken handoffs. Here's the integration architecture that closed the ...
Patent expiry has slashed semaglutide prices in India by up to 90%, but regulatory hurdles and newer drugs mean the global ...
DHAKA, April 26, 2026 (BSS) – Bangladesh’s pharmaceutical sector is expected to gain vital momentum if the proposed ...
TN IDMA secures regulatory breakthrough as TN govt digitizes methanol licensing via ‘e-Kalaal’ portal: Peethaambaran Kunnathoor, Chennai Monday, April 20, 2026, 08:00 Hrs [IST ...
Hydreight (HYDTF) has transformed into a 50-state healthcare infrastructure company, rapidly scaling VSDHOne licenses to 11K+ ...
SymphonyAI, a global leader in Vertical AI platforms, today announced eight new industrial AI applications purpose-built for energy operators, marking the most targeted expansion of IRIS Foundry into ...
As biz agentic bot-wrangling intensifies, company says AI orchestration, security and infrastructure tools on the way ...
Indonesia’s Food and Drug Monitoring Agency (BPOM) is encouraging the optimization of domestic drug production capacity as a ...
Zacks Small Cap Research on MSN

RVPH: Shareholder Letter Introduces New IP

By John Vandermosten, CFA NASDAQ: RVPH On behalf of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), Chief Executive Officer, Dr. Laxminarayan Bhat, composed a letter to shareholders ...